Winnoz Technology Co., Ltd.
Innovator of micro-sampling blood collection devices for diagnostics and health monitoring.
Winnoz develops the Haiimoo micro-sampling platform, a painless single-use capillary blood collection device that replaces venepuncture for dried blood spot and liquid biomarker collection. The technology enables home-based or remote patient testing for cholesterol, HbA1c, hormones and drug monitoring. The company has CE marking and is expanding into European clinical lab and telehealth channels.
- Type
- Manufacturer
- Location
- Hong Kong, China
- Founded
- 2017
- Website
- winnoz.com
- Categories
- Medical & Healthcare Supplies
- Markets
- China, Hong Kong, Singapore, United States, United Kingdom
Verified facts
- certificate-page-on-site (amber), checked 2026-08-11 Company's own certification page
- domain-registered (green), checked 2026-08-10 Domain registry record
- debarment-clear (green), checked 2026-08-10 OpenSanctions
- sanctions-clear (green), checked 2026-08-10 OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-10 Mail server of the company domain
Claimed certifications
- ISO 13485, Medical Devices Quality IAF CertSearch
- CE Marking EU NANDO (notified bodies)
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)